BeStock  
Stocks › Biotechnology › PVLA

Palvella Therapeutics PVLA

US equityMarket cap rank #2653Biotechnology
$142.85 −$2.92 (-2.00%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $142.85 0.00%
Open$143.10
Prev close$145.77
Day range$142.22 – $148.69
Volume192.7K
Market cap$2.09B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±5.5%last 8 reports
Closed higher3 of 838% of the time
Best reaction+12.6%
Worst reaction-13.0%

Stock move on the day after each report

-0.4%2024/Q4-0.4%2025/Q1+3.3%2025/Q2-3.0%2025/Q3+12.6%2025/Q4-13.0%2026/Q1+8.0%2026/Q2-3.3%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q35 Nov 2026Pre Market±8.8%-3.35%Within range
2026/Q24 Aug 2026Pre Market±11.1%+7.96%Within range
2026/Q17 May 2026Pre Market±8.4%-12.99%Bigger than priced
2025/Q431 Mar 2026Pre Market±12.2%+12.64%Bigger than priced
2025/Q311 Nov 2025Pre Market±10.0%-3.04%Within range
2025/Q214 Aug 2025Pre Market–+3.27%–
2025/Q115 May 2025Pre Market–-0.41%–
2024/Q431 Mar 2025Pre Market–-0.39%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00
Operating profit-$22.73M-123.3% YoY
Net profit-$24.64M-117.2% YoY
Diluted EPS-$1.70-65.0% YoY
Free cash flow-$14.43M-83.1% YoY
Operating cash flow-$14.43M

Revenue, last 8 quarters

$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$0.0Sep '26

Net profit, last 8 quarters

$-4.0MDec '24$-8.2MMar '25$-9.5MJun '25$-11.3MSep '25$-12.7MDec '25$-15.8MMar '26$-21.9MJun '26$-24.6MSep '26

Profitability & balance sheet

Return on equity-63.4%
Return on assets-49.0%
Return on invested capital-60.8%
Current ratio16.01
Liabilities / assets17.3%
Cash & investments$236.68M
Total debt$260,000.00
Net cash (debt)$236.42M

Discussion

No comments yet — be the first to weigh in on PVLA.

Sign in to join the discussion.

Scroll to Top